Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

The Use Of Histone Deacetylase (HDAC) Inhibitors For The Prevention And Cure Of Breast Cancer Brain Metastasis

  • Read more about The Use Of Histone Deacetylase (HDAC) Inhibitors For The Prevention And Cure Of Breast Cancer Brain Metastasis
US Application 60/891,856
Filed on 2007-02-27

IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE

  • Read more about IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE
US Application 60/995,212
Filed on 2007-09-24

Identification And Characterization Of A Mouse T Cell Receptor Recognizing HLA-A*0201 Restricted Human Melanoma Antigen Gp100154-162

  • Read more about Identification And Characterization Of A Mouse T Cell Receptor Recognizing HLA-A*0201 Restricted Human Melanoma Antigen Gp100154-162
US Application 60/885,724
Filed on 2007-01-19

A Gene Expression Signature Identifying Pro-angiogenic Genes In Ovarian Tumor Endothelial Cell Isolates

  • Read more about A Gene Expression Signature Identifying Pro-angiogenic Genes In Ovarian Tumor Endothelial Cell Isolates
US Application 60/901,455
Filed on 2007-02-14

Organ And Tumor Associated Endothelial Markers

  • Read more about Organ And Tumor Associated Endothelial Markers
US Application 60/879,457
Filed on 2007-01-08

Use Of SLCOlB3 Genotyping To Predict A Survival Prognosis Of Prostate Cancer

  • Read more about Use Of SLCOlB3 Genotyping To Predict A Survival Prognosis Of Prostate Cancer
US Application 60/879,503
Filed on 2007-01-08

Methods of Determining the Prognosis of an Adenocarcinoma

  • Read more about Methods of Determining the Prognosis of an Adenocarcinoma
US Application 60/885,101
Filed on 2007-01-16

SCGB3A2 as a Growth Factor and Anti-Apoptotic Agent

  • Read more about SCGB3A2 as a Growth Factor and Anti-Apoptotic Agent
US Application 60/880,134
Filed on 2007-01-12

The Use Of Human T-box Transcription Factor Brachyury As A Target For Cancer Imrnunotherapy And The Identification Of Epitopes Of Human Brachyury As Targets For Tcell Mediated Lysis Of Tumors

  • Read more about The Use Of Human T-box Transcription Factor Brachyury As A Target For Cancer Imrnunotherapy And The Identification Of Epitopes Of Human Brachyury As Targets For Tcell Mediated Lysis Of Tumors
US Application 60/904,236
Filed on 2007-02-28

GENE EXPRESSION PROFILE FOR PREDICTING OVARIAN CANCER PATIENT SURVIVAL

  • Read more about GENE EXPRESSION PROFILE FOR PREDICTING OVARIAN CANCER PATIENT SURVIVAL
US Application 60/951,073
Filed on 2007-07-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health